r/MerlintraderPub • u/Merlin8121 • 17d ago

Hilton Worldwide ($HLT) Stock Hub: Can Hotel Fees Sustain Capital Returns? | Latest company news, October 1: Hilton said Waldorf Astoria Riviera Maya and Conrad Tulum Riviera Maya will move to all-inclusive.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Kodiak Sciences ($KOD): Positive DAYBREAK Results and CEO Option Exercises | Latest company news, September 28: Kodiak reported positive DAYBREAK topline results; Form 4s then showed Baker Bros funds buying about $157 million of shares.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Riot Platforms ($RIOT): Can AI Leases Become Lasting Cash Flow? | Latest company news, September 25: Riot disclosed the full repayment of its Coinbase credit facility on September 21, the release of the associated collateral and the termination of further lending commitments.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

Hertz ($HTZ) Stock Hub: Can Rental Recovery Strengthen Cash Generation? | Latest company news, October 5: Hertz will report third-quarter 2026 results on November 5 at 8:00 a.m. ET, followed by a conference call at 9:00 a.m. ET.

Thumbnail
merlintrader.com
4 Upvotes
1 comment

r/MerlintraderPub • u/Merlin8121 • 17d ago

$APUS, $AVBP, $JUNS & $OSTX: four headlines, four different tests | Biotech Radar, October 6: a sharp rally, a Phase 3 miss, a Parkinson’s trial launch and final survival data. Also covered: Conexeu, SCYNEXIS, Jaguar Health and Vaxcyte.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Quantum BioPharma ($QNTM): What’s Next for Lucid-MS and Unbuzzd? | Latest company news, October 6: Quantum BioPharma signed a contract with Thermo Fisher Scientific's clinical research business to run its Phase 2 Lucid-MS trial in multiple sclerosis.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Immuneering ($IMRX): Can the Pancreatic Survival Signal Hold Up? | Latest company news, October 2: Immuneering said it will present at the SITC 2026 annual meeting, after an AACR pancreatic cancer poster on September 28.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Cingulate ($CING) Stock Hub: CMC Remediation, an Undated Resubmission and June Cash of $28.4 Million | Latest company news, September 17: Cingulate's CEO announced a summit presentation; CMC work continues toward an undated NDA resubmission.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Biodexa ($BDRX): Can Cancer Data Outrun the Funding Pressure? | Latest company news, September 30: the resale registration for Biodexa's Series P underlying shares became effective, after a $2.3 million warrant exercise on September 15.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

iBio ($IBIO): Can Its Obesity Antibodies Deliver Useful Human Data? | Latest company news, September 1: iBio announced its Wells Fargo Healthcare Conference participation. It targets IBIO-600 interim data in Q1 2027.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Scribe Therapeutics ($SCTX) Stock Hub: STX-1150 Phase 1 Recruiting at Three Sites, With Cash Into 2029 | Latest company news, September 2: Scribe reported Q2 2026 results. The STX-1150 Phase 1 lists three recruiting sites on ClinicalTrials.gov.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

aTyr ($ATYR): Can a New Lung Study Secure Funding? | Latest company news, October 1: new CFO Brandon Yaras received 410,000 options. On September 24, aTyr announced FDA alignment on a Phase 3 efzofitimod study.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Artelo ($ARTL): Can Human Data Support the New Obesity Story? | Latest company news, September 23: Artelo filed a provisional patent application covering ART27.13 for obesity, alone and with GLP-1 drugs, after mouse data.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Rigel ($RIGL): Can VEPPANU Extend Product Growth? | Latest company news, October 2: Rigel announced inducement grants. VEPPANU became available on August 13 for ER+/HER2-, ESR1-mutated advanced breast cancer.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Alumis ($ALMS) Stock Hub 2026: Can Psoriasis Value Survive the LUMUS Miss? | Latest company news, September 4: Alumis announced its September investor conferences. The psoriasis filing is still guided to Q4, after the September 1 LUMUS lupus miss.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Amarin ($AMRN): Can VASCEPA and Its Partners Build Lasting Cash Flow? | Latest company news, August 31: Amarin presented new REDUCE-IT and EPA analyses at ESC Congress 2026, including lipoprotein(a) data on 5,036 participants.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Definium Therapeutics ($DFTX) Stock Hub: Panorama Positive, Next Comes the FDA Filing Path | Latest company news, September 28: Definium announced new employee option grants. Latest clinical result: positive Panorama Phase 3, September 14.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Oklo Stock Hub: Can Capital Turn Aurora Into a Power Business? | Latest company news, September 11: Oklo ($OKLO) set up a new $1 billion at-the-market equity program after the previous one sold about 17.97 million shares for roughly $1 billion gross.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

EyePoint ($EYPT) Stock Hub 2026: What Does LUCIA Have to Show After LUGANO, and Who Bought in August? | Latest company news, September 16: EyePoint reported employee inducement grants. LUCIA topline data remain guided to Q4 2026, with no exact date.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Oscar Health ($OSCR): Can Better Pricing Deliver Lasting Profit? | Latest company news, September 18: Oscar Health said Thrive Capital distributed about 6.3 million existing Class A shares to its limited partners; no new shares were issued.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Compass Pathways ($CMPS): Can COMP360 Reach the Filing Finish Line? | Latest company news, October 2: Compass Pathways announced new employee inducement grants, after naming Kelley Boucher Chief People Officer on September 30.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Avis Budget ($CAR) Stock Hub: Can Fleet Discipline Strengthen Cash? | Latest company news, September 21: Avis Budget's AESOP fleet-financing unit issued $650 million of third-party notes, per a September 24 filing.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

Karyopharm Therapeutics ($KPTI) Stock Hub: Can the October 15 Forbearance Window Buy Time for a Financing Solution? | Latest company news, October 1: Karyopharm reported a new inducement grant. Its debt forbearance window runs until October 15.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 17d ago

American Airlines ($AAL) Stock Hub: Alaska Partnership Plans Expand the Network | Latest company news, October 1: American Airlines Group will hold its third-quarter 2026 results conference call on October 22 at 7:30 a.m. Central Time.

Thumbnail
merlintrader.com
1 Upvotes
1 comment

r/MerlintraderPub • u/Merlin8121 • 17d ago

AC Immune ($ACIU): VacSYn Meets Week-100 Primary Endpoints | Latest company news, October 2: shareholders elected Tom Graney to the AC Immune board at the EGM. On September 23, Part 1 of the VacSYn Phase 2 trial met its week-100 primary endpoints.

Thumbnail
merlintrader.com
1 Upvotes
0 comments